SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Apollo Hospitals’ rises as its arm plans to raise Rs 450 crore to fund expansion

19 Oct 2016 Evaluate

Apollo Hospitals Enterprise is currently trading at Rs. 1388.20, up by 15.55 points or 1.13% from its previous closing of Rs. 1372.65 on the BSE.

The scrip opened at Rs. 1385.00 and has touched a high and low of Rs. 1396.45 and Rs. 1379.10 respectively. So far 2,295 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 1544.00 on 02-Mar-2016 and a 52 week low of Rs. 1213.35 on 16-Nov-2015.

Last one week high and low of the scrip stood at Rs. 1396.45 and Rs. 1325.00 respectively. The current market cap of the company is Rs. 19,277.00 crore.

The promoters holding in the company stood at 34.35%, while Institutions and Non-Institutions held 46.13% and 18.97% respectively.

Apollo Hospitals Enterprise’s (AHEL) - Apollo Clinics, plans to raise Rs 450 crore for expanding the network of clinics. Apollo Clinics, which runs multi-speciality clinics, is part of the Apollo Health and Lifestyle (AHLL), a wholly-owned subsidiary of AHEL. It is also looking to dilute about 20% of its equity.

A player in the healthcare industry will pick up equity in the group’s arm to infuse the funds. The subsidiary will utilize the proceeds on expanding the number of clinics to 150 from the present 78.

Apollo Hospitals is the leading private sector healthcare provider in Asia and owns and manages a network of speciality hospitals and clinics, a chain of Pharmacy retail outlets across the country, and provides Consultancy Services for commissioning and managing the Speciality Hospitals.




Apollo Hospital Ent. Share Price

7699.05 143.10 (1.89%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×